SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-029212
Filing Date
2023-08-16
Accepted
2023-08-16 18:01:31
Documents
1
Period of Report
2023-08-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6481
  Complete submission text file 0001493152-23-029212.txt   7897
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3274 ROSS ROAD PALO ALTO CA 94303
Business Address
Anderson Glen R. (Reporting) CIK: 0001878961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 231179327